Ischemia Cli Product Applications In India

1 applications found

In India Available In India Near India

Potential breakthrough treatment option for Critical Limb Ischemia (CLI)

Our First DCGI Approved Stem Cell Product: Stempeucel® is the FIRST innovative stem cell based biological product to be approved by DCGI (Indian FDA) for manufacturing and marketing for the treatment of Critical Limb Ischemia (CLI). Stempeucel® product has been licensed to Cipla in India. ...

ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you